These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 33780087)

  • 1. Serpin neuropathology in the P497S UBQLN2 mouse model of ALS/FTD.
    Higgins NR; Greenslade JE; Wu JJ; Miranda E; Galliciotti G; Monteiro MJ
    Brain Pathol; 2021 Sep; 31(5):e12948. PubMed ID: 33780087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of UBQLN1 reduces neuropathology in the P497S UBQLN2 mouse model of ALS/FTD.
    Wang S; Tatman M; Monteiro MJ
    Acta Neuropathol Commun; 2020 Oct; 8(1):164. PubMed ID: 33028421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALS/FTD mutations in UBQLN2 impede autophagy by reducing autophagosome acidification through loss of function.
    Wu JJ; Cai A; Greenslade JE; Higgins NR; Fan C; Le NTT; Tatman M; Whiteley AM; Prado MA; Dieriks BV; Curtis MA; Shaw CE; Siddique T; Faull RLM; Scotter EL; Finley D; Monteiro MJ
    Proc Natl Acad Sci U S A; 2020 Jun; 117(26):15230-15241. PubMed ID: 32513711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALS/FTD mutations in UBQLN2 are linked to mitochondrial dysfunction through loss-of-function in mitochondrial protein import.
    Lin BC; Phung TH; Higgins NR; Greenslade JE; Prado MA; Finley D; Karbowski M; Polster BM; Monteiro MJ
    Hum Mol Genet; 2021 Jun; 30(13):1230-1246. PubMed ID: 33891006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippocampal aggregation signatures of pathogenic UBQLN2 in amyotrophic lateral sclerosis and frontotemporal dementia.
    Thumbadoo KM; Dieriks BV; Murray HC; Swanson MEV; Yoo JH; Mehrabi NF; Turner C; Dragunow M; Faull RLM; Curtis MA; Siddique T; Shaw CE; Newell KL; Henden L; Williams KL; Nicholson GA; Scotter EL
    Brain; 2024 Oct; 147(10):3547-3561. PubMed ID: 38703371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling UBQLN2-mediated neurodegenerative disease in mice: Shared and divergent properties of wild type and mutant UBQLN2 in phase separation, subcellular localization, altered proteostasis pathways, and selective cytotoxicity.
    Sharkey LM; Sandoval-Pistorius SS; Moore SJ; Gerson JE; Komlo R; Fischer S; Negron-Rios KY; Crowley EV; Padron F; Patel R; Murphy GG; Paulson HL
    Neurobiol Dis; 2020 Sep; 143():105016. PubMed ID: 32653673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS-FTD-linked UBQLN2 mutations.
    Le NT; Chang L; Kovlyagina I; Georgiou P; Safren N; Braunstein KE; Kvarta MD; Van Dyke AM; LeGates TA; Philips T; Morrison BM; Thompson SM; Puche AC; Gould TD; Rothstein JD; Wong PC; Monteiro MJ
    Proc Natl Acad Sci U S A; 2016 Nov; 113(47):E7580-E7589. PubMed ID: 27834214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of ubiquilin 2 and TDP-43 aggregates throughout the CNS in UBQLN2 p.T487I-linked amyotrophic lateral sclerosis and frontotemporal dementia.
    Nementzik LR; Thumbadoo KM; Murray HC; Gordon D; Yang S; Blair IP; Turner C; Faull RLM; Curtis MA; McLean C; Nicholson GA; Swanson MEV; Scotter EL
    Brain Pathol; 2024 May; 34(3):e13230. PubMed ID: 38115557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UBQLN2-HSP70 axis reduces poly-Gly-Ala aggregates and alleviates behavioral defects in the C9ORF72 animal model.
    Zhang K; Wang A; Zhong K; Qi S; Wei C; Shu X; Tu WY; Xu W; Xia C; Xiao Y; Chen A; Bai L; Zhang J; Luo B; Wang W; Shen C
    Neuron; 2021 Jun; 109(12):1949-1962.e6. PubMed ID: 33991504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia.
    Renaud L; Picher-Martel V; Codron P; Julien JP
    Acta Neuropathol Commun; 2019 Jul; 7(1):103. PubMed ID: 31319884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global proteomics of Ubqln2-based murine models of ALS.
    Whiteley AM; Prado MA; de Poot SAH; Paulo JA; Ashton M; Dominguez S; Weber M; Ngu H; Szpyt J; Jedrychowski MP; Easton A; Gygi SP; Kurz T; Monteiro MJ; Brown EJ; Finley D
    J Biol Chem; 2021; 296():100153. PubMed ID: 33277362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants.
    Strohm L; Hu Z; Suk Y; Rühmkorf A; Sternburg E; Gattringer V; Riemenschneider H; Berutti R; Graf E; Weishaupt JH; Brill MS; Harbauer AB; Dormann D; Dengjel J; Edbauer D; Behrends C
    Life Sci Alliance; 2022 Nov; 5(11):. PubMed ID: 35777956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion protein pathology in Ubiquilin 2 models of ALS.
    Le NT; Chu N; Joshi G; Higgins NR; Nebie O; Adelakun N; Butts M; Monteiro MJ
    Neurobiol Dis; 2024 Oct; 201():106674. PubMed ID: 39299489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UBQLN2 undergoes a reversible temperature-induced conformational switch that regulates binding with HSPA1B: ALS/FTD mutations cripple the switch but do not destroy HSPA1B binding.
    Phung TH; Tatman M; Monteiro MJ
    Biochim Biophys Acta Gen Subj; 2023 Feb; 1867(2):130284. PubMed ID: 36423739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axon guidance genes modulate neurotoxicity of ALS-associated UBQLN2.
    Kim SH; Nichols KD; Anderson EN; Liu Y; Ramesh N; Jia W; Kuerbis CJ; Scalf M; Smith LM; Pandey UB; Tibbetts RS
    Elife; 2023 Apr; 12():. PubMed ID: 37039476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyotrophic lateral sclerosis-linked UBQLN2 mutants inhibit endoplasmic reticulum to Golgi transport, leading to Golgi fragmentation and ER stress.
    Halloran M; Ragagnin AMG; Vidal M; Parakh S; Yang S; Heng B; Grima N; Shahheydari H; Soo KY; Blair I; Guillemin GJ; Sundaramoorthy V; Atkin JD
    Cell Mol Life Sci; 2020 Oct; 77(19):3859-3873. PubMed ID: 31802140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyotrophic lateral sclerosis (ALS) linked mutation in Ubiquilin 2 affects stress granule assembly via TIA-1.
    Peng G; Gu A; Niu H; Chen L; Chen Y; Zhou M; Zhang Y; Liu J; Cai L; Liang D; Liu X; Liu M
    CNS Neurosci Ther; 2022 Jan; 28(1):105-115. PubMed ID: 34750982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALS-linked mutations impair UBQLN2 stress-induced biomolecular condensate assembly in cells.
    Riley JF; Fioramonti PJ; Rusnock AK; Hehnly H; Castañeda CA
    J Neurochem; 2021 Oct; 159(1):145-155. PubMed ID: 34129687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic mutations in UBQLN2 exhibit diverse aggregation propensity and neurotoxicity.
    Safren N; Dao TP; Mohan HM; Huang C; Trotter B; Castañeda CA; Paulson H; Barmada S; Sharkey LM
    Sci Rep; 2024 Mar; 14(1):6049. PubMed ID: 38472280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UBQLN2/P62 cellular recycling pathways in amyotrophic lateral sclerosis and frontotemporal dementia.
    Fecto F; Siddique T
    Muscle Nerve; 2012 Feb; 45(2):157-62. PubMed ID: 22246868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.